The distribution of iron-carbon nanoparticles in FeC-DSPE-PEG-2000 modification (micellar particles with structure (Fe) core-carbon shell; PEG-based coating) is studied. The greater part of the nanoparticles accumulated in the spleen and liver, a small amount in the lungs, and the minimum amount in the thymus. The structural changes in the lymphoid organs were minor and involved only the microcirculatory bed. Analysis of the peripheral blood showed manifest anemia, thrombocytopenia, and leukocytosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Milto IV, Mikhaylov GA, Ratkin AV, Magaeva AA. Influence nanoparticles on morphology of internal organs of the mouse at intravenous introduction of a solution nanopowder Fe3O4. Byull. Sib. Med. 2008;7(1):32-36. Russian.
Yushkov BG, Artashyan OS, Medvedeva SYu, Byzov IV, Uimin MA, Ermakov AE, Bykova MYu, Petrova IM. Evaluation of biodistribution of functionalized magnetic core/carbon-shell nanoparticles in systemic method of administration. Bull. Exp. Biol. Med. 2015;159(4):495-499.
Ban M, Langonné I, Huguet N, Goutet M. Effect of submicron and nano-iron oxide particles on pulmonary immunity in mice. Toxicol. Lett. 2012;210(3):267-275.
Fenske DB, Chonn A, Cullis PR. Liposomal nanomedicines: an emerging field. Toxicol. Pathol. 2008;36(1):21-29.
Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 2003;348(25):2491-2499.
Kam NW, O’Connell M, Wisdom JA, Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl Acad. Sci. USA. 2005;102(33):11 600-11 605.
Kularatne BY, Lorigan P, Browne S, Suvarna SK, Smith MO, Lawry J. Monitoring tumour cells in the peripheral blood of small cell lung cancer patients. Cytometry. 2002;50(3):160-167.
Maeda H, Bharate GY, Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur. J. Pharm. Biopharm. 2009;71(3):409-419.
Maeda H, Sawa T, Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Control. Release. 2001;74(1-3):47-61.
Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J. 2005;19(3):311-330.
Park JH, Lee S, Kim JH, Kwon IC. Polymeric nanomedicine for cancer therapy. Prog. Polym. Sci. 2008;33(1):113-137.
Piotrovsky L, Kiselev OI. Fullerenes and viruses. Fuller. Nanotub. Car. N. 2006;12(1-2):397-403.
Suzuki R, Takizawa T, Kuwata Y, Mutoh M, Ishiguro N, Utoguchi N, Shinohara A, Eriguchi M, Yanagie H, Maruyama K. Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome. Int. J. Pharm. 2008;346(1-2):143-150.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 162, No. 8, pp. 218-221, August, 2016
Rights and permissions
About this article
Cite this article
Khramtsova, Y.S., Tyumentseva, N.V., Yushkov, B.G. et al. Reaction of Lymphoid Organs to Injection of Iron-Carbon Nanoparticles. Bull Exp Biol Med 162, 252–254 (2016). https://doi.org/10.1007/s10517-016-3588-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-016-3588-7